Zobrazeno 1 - 10
of 99
pro vyhledávání: '"Honeymoon phase"'
Autor:
Isabella Sued Leão, Joana Rodrigues Dantas, Débora Baptista Araújo, Maria Eduarda Nascimento Ramos, Karina Ribeiro Silva, Leandra S. Batista, Maria de Fátima Carvalho Pereira, Ronir Raggio Luiz, César Cláudio da Silva, Angelo Maiolino, Carmen Lúcia Kuniyoshi Rebelatto, Débora Regina Daga, Alexandra Cristina Senegaglia, Paulo Roberto Slud Brofman, José Egídio Paulo de Oliveira, Lenita Zajdenverg, Melanie Rodacki
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 16, Iss 1, Pp 1-9 (2024)
Abstract Background Mesenchymal stem cell infusion and vitamin D supplementation may have immunomodulatory actions that could prolong the preservation of residual insulin secretion in patients with type 1 diabetes (T1D). Intervention with these agent
Externí odkaz:
https://doaj.org/article/d82fa06687334844b70769c7a3a11909
Autor:
Pranjali Shah
Publikováno v:
Journal of Diabetology, Vol 15, Iss 2, Pp 238-240 (2024)
Type 1 diabetes mellitus (T1DM) exhibits heterogeneity in presentation, and the “honeymoon” period, characterized by temporary beta-cell function restoration, is a significant aspect influencing disease progression. Adult-onset T1DM differs from
Externí odkaz:
https://doaj.org/article/0125ae22098f4b44bb801bdd382fdf16
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Marcelo Maia Pinheiro, Felipe Moura Maia Pinheiro, Marcelo Müller de Arruda, Geane Moron Beato, Graciele Alves Corrêa Lima Verde, Georgiana Bianchini, Pedro Rosário Moraes Casalenuovo, Aline Aparecida Agostini Argolo, Lucilene Telles de Souza, Flávia Gomes Pessoa, Thiago Santos Hirose, Eduardo Filgueiras Senra, Camillo Ricordi, Andrea Fabbri, Marco Infante, Susana Nogueira Diniz
Publikováno v:
Archives of Endocrinology and Metabolism, Vol 67, Iss 5 (2023)
ABSTRACT Objective: The occurrence of partial remission (honeymoon phase) in type 1 diabetes (T1D) has been associated with a reduced risk of chronic microvascular complications of diabetes. We have published case reports showing that a combination t
Externí odkaz:
https://doaj.org/article/9d74899d9f984e3ab2ada60c44c48448
Autor:
Benjamin Udoka Nwosu
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
The publication of our recent randomized controlled trial (RCT) showing that vitamin D could protect the β-cells during the honeymoon phase of type 1 diabetes (T1D) has led to calls for guidance for vitamin D supplementation during the critical phas
Externí odkaz:
https://doaj.org/article/61e09c79f0674e7e9814a03853b6cbea
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Benjamin Udoka Nwosu
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
Despite advances in the characterization of partial clinical remission (PR) of type 1 diabetes, an accurate definition of PR remains problematic. Two recent studies in children with new-onset T1D demonstrated serious limitations of the present gold s
Externí odkaz:
https://doaj.org/article/030157f425e048738996babdbb7f8720
Autor:
Benjamin Udoka Nwosu
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
Literature Search CriteriaA literature search was conducted to identify publications addressing the early phases of lipid phenotypes in children and adults with either type 1 diabetes or type 2 diabetes. Medline, EMBASE, and Ovid were searched using
Externí odkaz:
https://doaj.org/article/d4fb354f84f7452fa58b915f2d917f96
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Benjamin Udoka Nwosu, Sadichchha Parajuli, Krish Khatri, Gabrielle Jasmin, Layana Al-Halbouni, Austin F. Lee
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
ImportanceRisk factors for atherosclerotic cardiovascular disease (ASCVD) are well established in type 2 diabetes (T2D), but not in type 1 diabetes (T1D). The impact of partial clinical remission (PR) on short-term ASCVD risk in T1D is unclear.AimTo
Externí odkaz:
https://doaj.org/article/31ba85162293457e91654a534717c767